300357 Zhejiang Wolwo Bio-Pharmaceutical
- 24.89
- -0.13-0.52%
Zhejiang Wolwo Bio-Pharmaceutical News
Wawu Biotech: Investor Relations Activity Record Form for October 24, 2024
Obu Biotech: Report for the third quarter of 2024
Wuwu Biotech: Announcement of Resolutions of the 9th Meeting of the Fifth Board of Directors
Wuwu Biotech: Announcement of Resolutions of the 7th Meeting of the Fifth Board of Supervisors
Wowu Biotech: Announcement on the Profit Distribution Plan for the First Three Quarters of 2024
Wuwu Biotech: Notice on Obtaining a Notice of Acceptance of Applications for Clinical Trials of House Dust Mite Membranes
Wuwu Biotech: Announcement on the progress of matters involving the company in litigation
Wowu Biotech: Announcement on the joint company obtaining a clinical trial summary report for products under development
Zhejiang Wolwo Bio-Pharmaceutical: 300357 zhejiang wolwo bio-pharmaceutical investor relations management information 20240825
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of the Supervisory Board's resolution.
Zhejiang Wolwo Bio-Pharmaceutical: Summary table of non-operational fund utilization and other related fund transactions (as of June 30, 2024)
Zhejiang Wolwo Bio-Pharmaceutical: Summary of Half-Year Report in 2024.
Zhejiang Wolwo Bio-Pharmaceutical: The Management System of Shareholdings and Changes in Holdings of Directors, Supervisors, and Senior Management Personnel (August 2024).
Zhejiang Wolwo Bio-Pharmaceutical: Half-year report for the year 2024.
Zhejiang Wolwo Bio-Pharmaceutical: Board of directors resolution announcement.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement on the Entry of the First Subject in Phase II Clinical Trial of Dermatitis Diagnostic Patch 01
Zhejiang Wolwo Bio-Pharmaceutical: Announcement Regarding Company-Related Litigation.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of Annual Equity Distribution Implementation in 2023
Zhejiang Wolwo Bio-Pharmaceutical: Investor Relations Activity Records for June 14, 2024.
Zhejiang Wolwo Bio-Pharmaceutical: Announcement of the Resolution of the Seventh Meeting of the Fifth Board of Directors.
Analysis
Price Target
No Data
No Data